Health Canada grants conditional approval for Ondexxya to reverse FXa inhibitor anticoagulant effectsAndexanet alfa will be used intravenously to rapidly reverse life-threatening or uncontrolled bleeding due to rivaroxaban or apixaban. NVAF patients often don't get the right dosesUnderdosing associated with less-consistent long-term anticoagulation, worse adherence. Guidelines propose new way to define ‘death’ Beyond providing a harmonized definition of death, guidelines present updated criteria for determining death in the event of devastating brain injury or circulatory arrest. Not all sugars created equal: Maple syrup may reduce cardiometabolic risk Researchers surprised by the significant reduction in abdominal fat for participants using maple syrup. Daily low-dose ASA use in elderly patients increases the risk of anemia Study finds an increase in anemia and a decline in ferritin in otherwise healthy older adults taking daily low-dose acetylsalicylic acid. Myocardial infarction leads to speedier decline in cognition, brain health Recent research found the changes become more pronounced as time goes on. One in three diabetics found to have undetected heart disease Should biomarkers be used to screen more people? Popular ‘low T’ treatment is safe for men with heart disease, but doctors warn it’s no youth serum More than 5,000 men ages 45-80 at 316 trial sites throughout the U.S. were randomly assigned to get the testosterone gel or the placebo. Statins for the primary prevention of cardiovascular disease The 2021 CCS dyslipidemia guidelines recommend statin therapy for certain higher-risk primary prevention patients. Newer heart transplant method could allow more patients a chance at lifesaving surgery It’s called donation after circulatory death, a method long used to recover kidneys and other organs but not more fragile hearts. First Previous 9 10 11 12 13 Next Last
